vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and WOLVERINE WORLD WIDE INC (WWW). Click either name above to swap in a different company.
WOLVERINE WORLD WIDE INC is the larger business by last-quarter revenue ($517.5M vs $284.0M, roughly 1.8× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 6.1%, a 90.2% gap on every dollar of revenue. On growth, WOLVERINE WORLD WIDE INC posted the faster year-over-year revenue change (25.5% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 14.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Wolverine World Wide is a global designer, manufacturer and marketer of branded footwear, apparel and accessories. It owns popular brands including Merrell, Sperry, Saucony and Hush Puppies, serving outdoor, casual, workwear and athletic segments via e-commerce, retail stores and global wholesale networks.
ACAD vs WWW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $517.5M |
| Net Profit | $273.6M | $31.8M |
| Gross Margin | 90.8% | 47.3% |
| Operating Margin | 6.1% | 9.7% |
| Net Margin | 96.3% | 6.1% |
| Revenue YoY | 9.4% | 25.5% |
| Net Profit YoY | 90.3% | 162.8% |
| EPS (diluted) | $1.61 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $517.5M | ||
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $470.3M | ||
| Q2 25 | $264.6M | $474.2M | ||
| Q1 25 | $244.3M | $412.3M | ||
| Q4 24 | $259.6M | $494.7M | ||
| Q3 24 | $250.4M | $440.2M | ||
| Q2 24 | $242.0M | $425.2M |
| Q1 26 | — | $31.8M | ||
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $25.1M | ||
| Q2 25 | $26.7M | $26.8M | ||
| Q1 25 | $19.0M | $12.1M | ||
| Q4 24 | $143.7M | $23.1M | ||
| Q3 24 | $32.8M | $23.2M | ||
| Q2 24 | $33.4M | $13.8M |
| Q1 26 | — | 47.3% | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | 47.5% | ||
| Q2 25 | 92.2% | 47.2% | ||
| Q1 25 | 91.7% | 47.2% | ||
| Q4 24 | 91.6% | 43.4% | ||
| Q3 24 | 92.5% | 45.1% | ||
| Q2 24 | 92.5% | 43.1% |
| Q1 26 | — | 9.7% | ||
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | 8.4% | ||
| Q2 25 | 12.2% | 8.6% | ||
| Q1 25 | 7.9% | 4.8% | ||
| Q4 24 | 59.1% | 7.4% | ||
| Q3 24 | 12.6% | 7.9% | ||
| Q2 24 | 12.6% | 6.8% |
| Q1 26 | — | 6.1% | ||
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 5.3% | ||
| Q2 25 | 10.1% | 5.7% | ||
| Q1 25 | 7.8% | 2.9% | ||
| Q4 24 | 55.4% | 4.7% | ||
| Q3 24 | 13.1% | 5.3% | ||
| Q2 24 | 13.8% | 3.2% |
| Q1 26 | — | $0.37 | ||
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | $0.30 | ||
| Q2 25 | $0.16 | $0.32 | ||
| Q1 25 | $0.11 | $0.15 | ||
| Q4 24 | $0.86 | $0.29 | ||
| Q3 24 | $0.20 | $0.28 | ||
| Q2 24 | $0.20 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | — |
| Total DebtLower is stronger | — | $621.7M |
| Stockholders' EquityBook value | $1.2B | $408.0M |
| Total Assets | $1.6B | $1.7B |
| Debt / EquityLower = less leverage | — | 1.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | — | ||
| Q2 24 | $177.1M | — |
| Q1 26 | — | $621.7M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $676.4M | ||
| Q2 25 | — | $708.5M | ||
| Q1 25 | — | $710.8M | ||
| Q4 24 | — | $648.0M | ||
| Q3 24 | — | $702.8M | ||
| Q2 24 | — | $814.7M |
| Q1 26 | — | $408.0M | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | $376.7M | ||
| Q2 25 | $822.4M | $344.0M | ||
| Q1 25 | $765.2M | $310.6M | ||
| Q4 24 | $732.8M | $312.9M | ||
| Q3 24 | $577.2M | $295.2M | ||
| Q2 24 | $516.7M | $262.1M |
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | $1.7B | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.1B | $1.7B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $976.9M | $1.8B | ||
| Q2 24 | $914.1M | $1.8B |
| Q1 26 | — | 1.52× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.29× | ||
| Q4 24 | — | 2.07× | ||
| Q3 24 | — | 2.38× | ||
| Q2 24 | — | 3.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $146.2M |
| Free Cash FlowOCF − Capex | — | $145.6M |
| FCF MarginFCF / Revenue | — | 28.1% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | -0.18× | 4.60× |
| TTM Free Cash FlowTrailing 4 quarters | — | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $146.2M | ||
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $33.0M | ||
| Q2 25 | $64.0M | $44.6M | ||
| Q1 25 | $20.3M | $-83.8M | ||
| Q4 24 | $40.4M | $82.4M | ||
| Q3 24 | $63.2M | $108.2M | ||
| Q2 24 | $25.0M | $26.7M |
| Q1 26 | — | $145.6M | ||
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $30.1M | ||
| Q2 25 | — | $41.2M | ||
| Q1 25 | — | $-91.4M | ||
| Q4 24 | — | $74.4M | ||
| Q3 24 | $63.2M | $104.1M | ||
| Q2 24 | — | $23.7M |
| Q1 26 | — | 28.1% | ||
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | 6.4% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | -22.2% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | 25.2% | 23.6% | ||
| Q2 24 | — | 5.6% |
| Q1 26 | — | 0.1% | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 0.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | — | 0.7% |
| Q1 26 | — | 4.60× | ||
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 1.31× | ||
| Q2 25 | 2.40× | 1.66× | ||
| Q1 25 | 1.07× | -6.93× | ||
| Q4 24 | 0.28× | 3.57× | ||
| Q3 24 | 1.93× | 4.66× | ||
| Q2 24 | 0.75× | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
WWW
| Sales Channel Through Intermediary | $230.2M | 44% |
| Sales Channel Directly To Consumer | $142.6M | 28% |
| Work Group | $134.0M | 26% |
| Other | $10.7M | 2% |
